Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gooley

Showing results (751-760 of 889) with videos related to

Pageof 89
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2013
Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humansEric Chern-Pin Chua, Guanghou Shui, Ivan Tian-Guang Lee, et al.
Nature Communications|December 9, 2023
Unravelling the mechanism of neurotensin recognition by neurotensin receptor 1Kazem Asadollahi, Sunnia Rajput, Lazarus Andrew de Zhang, et al.
Cell Reports|November 14, 2019
Structural Elucidation of Viral Antagonism of Innate Immunity at the STAT1 InterfaceMd Alamgir Hossain, Florence Larrous, Stephen M Rawlinson, et al.
Cell Death and Differentiation|March 10, 2022
Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKLAshish Sethi, Christopher R Horne, Cheree Fitzgibbon, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1Fabian Bumbak, Trayder Thomas, Billy J Noonan-Williams, et al.
Transplantation and Cellular Therapy|March 30, 2021
Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host DiseaseJane Turner, Qianchuan He, Kelsey Baker, et al.
Blood Advances|October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphomaVictor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Blood|September 30, 2009
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndromeJohn M Pagel, Theodore A Gooley, Joseph Rajendran, et al.
Haematologica|October 5, 2019
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasiaPhuong Vo, Ted A Gooley, Joseph G Rajendran, et al.
Transplantation and Cellular Therapy|December 7, 2025
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily C Merkel, Ted Gooley, Monica S Thakar, et al.
Pageof 89

Showing results (751-760 of 889) with videos related to

Sort By:
Pageof 89
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2013
Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humansEric Chern-Pin Chua, Guanghou Shui, Ivan Tian-Guang Lee, et al.
Nature Communications|December 9, 2023
Unravelling the mechanism of neurotensin recognition by neurotensin receptor 1Kazem Asadollahi, Sunnia Rajput, Lazarus Andrew de Zhang, et al.
Cell Reports|November 14, 2019
Structural Elucidation of Viral Antagonism of Innate Immunity at the STAT1 InterfaceMd Alamgir Hossain, Florence Larrous, Stephen M Rawlinson, et al.
Cell Death and Differentiation|March 10, 2022
Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKLAshish Sethi, Christopher R Horne, Cheree Fitzgibbon, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1Fabian Bumbak, Trayder Thomas, Billy J Noonan-Williams, et al.
Transplantation and Cellular Therapy|March 30, 2021
Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host DiseaseJane Turner, Qianchuan He, Kelsey Baker, et al.
Blood Advances|October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphomaVictor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Blood|September 30, 2009
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndromeJohn M Pagel, Theodore A Gooley, Joseph Rajendran, et al.
Haematologica|October 5, 2019
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasiaPhuong Vo, Ted A Gooley, Joseph G Rajendran, et al.
Transplantation and Cellular Therapy|December 7, 2025
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily C Merkel, Ted Gooley, Monica S Thakar, et al.
Pageof 89